Ablation vs. surgery for overactive parathyroid glands
Part of Hormones & metabolism clinical trials.
This trial compares two treatments for secondary hyperparathyroidism, a condition where the parathyroid glands make too much hormone, causing bone and muscle problems. It tests whether a needle-based heat treatment (thermal ablation) works as well as surgery to remove the glands, aiming to reduce hormone levels and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your parathyroid hormone level is very high (above 800 pg/mL)
- Medicines like calcimimetics and vitamin D have not controlled your condition
- You have symptoms like severe bone or muscle pain, weak bones, or calcium deposits in tissues
- An imaging test like an ultrasound has shown at least one enlarged parathyroid gland
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to treat primary hyperparathyroidism: a minimally invasive procedure (thermal ablation) that uses heat to destroy the overactive gland, versus surgery to remove it. The goal is to see which approach better manages symptoms and prevents complications.
This trial tests combining heat treatment of the thyroid gland with antithyroid medications to treat primary hyperthyroidism (an overactive thyroid). It may help patients who haven't responded well to standard drugs, had side effects, or want faster symptom relief.
This trial compares two surgical approaches for severe secondary hyperparathyroidism caused by kidney disease: removing all parathyroid tissue alone versus removing it and moving some tissue back into the body. The study aims to see which approach works better and is safer for controlling the hormone problem.
This trial looks at whether removing overactive parathyroid glands (parathyroidectomy) can help people who still have high calcium or low phosphate levels more than 6 months after a kidney transplant. If you have stable kidney function and meet certain blood test results, you may be able to join.
This trial gives access to a special imaging agent (18F-Fluorocholine) that helps doctors see overactive parathyroid glands, which can cause high calcium. It may help find the exact location of the problem before surgery.
This study compares a newer type of scan (18F-choline PET/CT) to standard imaging to help doctors locate overactive parathyroid glands. The goal is to see if the newer scan works better for planning surgery in people with primary hyperparathyroidism.
Hear when a new Efficacy and Safety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.